Avicanna Inc (AVCN.TO) has seen a notable decline this week amid a backdrop of limited news.
This week, Avicanna Inc's stock has decreased by 3.70%, closing at C$0.14. The company has not announced any major developments recently, leaving investors to interpret the market's reaction amidst its ongoing challenges in the health care sector.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$17.47M
52W high
$0.30
52W low
$0.10
1W change
-3.70%
Beta
0.33
Analyst Price Targets
Based on analyst covering AVCN
Wall Street analysts forecast AVCN stock price to rise 438.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+438.5% Upside
Current Price
C$0.13
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
66.8%
Annualized
90-Day Vol
66.4%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.13
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.13 | C$0.10 – C$0.16 |
| 60 trading days | C$0.13 | C$0.09 – C$0.18 |
| 90 trading days | C$0.13 | C$0.09 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the current technical indicators and the broader context of the health care market as they evaluate Avicanna's stock performance.
Avicanna's stock has dropped 3.70% this week, with a market cap of approximately C$17.5 million.
Despite a significant drop in share price, analysts project a potential upside of 400% based on average target estimates.
Bull case
Analysts are optimistic, with an average target price of C$0.70. This suggests that there’s considerable upside potential, especially considering recent product launches and the company’s financial performance.
Bear case
The stock has declined 40.91% year-to-date, and its negative profit margins indicate ongoing financial challenges. These factors could continue to impact future performance negatively.
Price Action Overview
Avicanna Inc's stock has declined by 3.70% over the past week, closing at C$0.14. This continues the downward trend seen throughout the year, with a year-to-date loss of 40.91%. The stock's performance reflects broader challenges within the health care sector, particularly for companies in the cannabis space.
Advertisement
Recent Company Developments
Despite the recent price action, there have been no significant announcements from Avicanna in the past week. However, the company previously reported record quarterly revenue in Q2 2026, highlighting growth attributed to its proprietary product portfolio and Canadian market expansion. Investors may want to keep an eye on future product launches and financial results as potential catalysts for recovery.
Technical Picture
Currently, Avicanna's stock trades below both its 50-day moving average of C$0.13 and its 200-day moving average of C$0.17. This indicates bearish momentum in the short and long term. The stock has a 52-week range of C$0.10 to C$0.30, with the current price at approximately 22% of that range. The beta of 0.33 suggests lower volatility compared to the broader market. With a trading volume of just 3,505 shares against a 20-day average of 52,154 shares, liquidity is also a concern.
Insider Activity
No recent insider activity has been reported for Avicanna, which can be a vital indicator for potential shifts in company strategy or confidence from leadership.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
